Jim Simons Dr Reddys Laboratories LTD Transaction History
Renaissance Technologies LLC
- $56.7 Billion
- Q2 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Renaissance Technologies LLC holds 1,995,495 shares of RDY stock, worth $148 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
1,995,495
Previous 1,929,889
3.4%
Holding current value
$148 Million
Previous $142 Million
7.4%
% of portfolio
0.27%
Previous 0.22%
Shares
23 transactions
Others Institutions Holding RDY
# of Institutions
232Shares Held
24MCall Options Held
14.6KPut Options Held
2.8K-
Robeco Institutional Asset Management B.V.2.07MShares$153 Million0.33% of portfolio
-
Royal Bank Of Canada Toronto, A62.06MShares$152 Million0.04% of portfolio
-
Morgan Stanley New York, NY2.03MShares$150 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.8MShares$133 Million0.0% of portfolio
-
Aikya Investment Management LTD London, X01.39MShares$103 Million30.55% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $12.3B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...